The COVID Advisor

The number of vaccines given to babies and children has increased dramatically without the necessary due diligence by regulatory authorities. Parents are urged to adopt a common-sense, ‘Safer to Wait” approach. Growing international concerns about vaccine regulatory processes and vaccine safety have emerged following the widespread regulatory failure of Covid-19 vaccines. The Covid-19 crisis has demonstrated that regulatory bodies, once public watchdogs, are now at best incompetent and at worst have been deeply corrupted by pharmaceutical industry interests. In the context of emerging revelations of regulatory body incompetence and corruption, e.g. The Perseus Report , the WCH Health and Science Committee notes that: Several research studies now indicate that vaccinated children have far worse health outcomes with higher rates of many chronic diseases than non-vaccinated children. The integrity of scientific research and the regulatory process of childhood vaccines, including the new n

Most children with COVID-19 handle the virus well and recover fully. Despite a lot of fear-mongering, COVID is not a deadly disease for most children. In fact, data show that the death rate is extremely low in patients under 17 years old. This guide aims to help you understand the real risks and know how to respond. The best thing you can do is focus on making sure your child is healthy overall and that their immune system is strong and robust. Recommended Therapies Here's the summary (details and dosing below): Vitamin D : Adequate Vitamin D levels help our bodies fight inflammation and boosts immunity. Vitamin C : An excellent antiviral that protects against a wide variety of viruses including COVID-19. Vitamin A : Found in red, yellow, and orange vegetables and a main component in cod liver oil. Zinc :

The latest SARS-CoV-2 variant, JN.1, was first detected in the U.S. in September 2023. By mid-December, it accounted for about half of all COVID cases in the country (1), and calls to get the latest “updated” COVID shot resumed. As of the week ending January 20, 2024, JN.1 represent an estimated 86% of the SARS-CoV-2 variants currently circulating in the United States,  according  to the CDC. Cases associated with this variant are also on the rise in the U.K., China and India. (2) According to the U.S. Centers for Disease Control and Prevention, the rapid spread of JN.1 suggests it may be more transmissible and/or has greater immune-evading abilities: (3) “JN.1 is similar to BA.2.86 but has an additional mutation (L455S) in the spike protein. JN.1 continues to cause an increasing share of infections and is now the most widely circulating variant in the United States. For the two weeks ending on December 23, 2023, JN.1 is expected to account for 39-50% of all SARS-CoV-2 variants. That’s